# Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

> **NCT03457753** · PHASE2 · WITHDRAWN · sponsor: **Aquestive Therapeutics**

## Conditions studied

- ALS

## Interventions

- **DRUG:** Riluzole Oral Soluble Film

## Key facts

- **NCT ID:** NCT03457753
- **Lead sponsor:** Aquestive Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03-01
- **Primary completion:** 2018-03-27
- **Final completion:** 2018-03-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The Sponsor stopped the study due to a change in study plans
- **Last updated:** 2019-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03457753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03457753, "Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03457753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*